dexmedetomidine has been researched along with baclofen in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (57.14) | 24.3611 |
2020's | 3 (42.86) | 2.80 |
Authors | Studies |
---|---|
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Heard, CM; Li, V; Morr, S; Reynolds, RM | 1 |
Bulloch, MN; Burry, L; Chan, C; Devabhakthuni, S; Dixit, D; Endicott, J; Ramos, L; Tobia, A; Yeung, SY | 1 |
Hardman, MI; Sprung, J; Weingarten, TN | 1 |
Laroche, JP | 1 |
Ahmed, S; Brewer, T; Defayette, A; Perrello, A; Picano, J | 1 |
Doi, M; Irifune, M; Kanematsu, T; Morioka, N; Mukai, A; Nakata, Y; Ogawa, Y; Oue, K; Sakai, N; Shimizu, Y; Yoshida, M | 1 |
3 review(s) available for dexmedetomidine and baclofen
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Management of Acute Alcohol Withdrawal Syndrome in Critically Ill Patients.
Topics: Baclofen; Benzodiazepines; Critical Illness; Dexmedetomidine; Ethanol; Humans; Length of Stay; Phenobarbital; Substance Withdrawal Syndrome | 2016 |
Acute phenibut withdrawal: A comprehensive literature review and illustrative case report.
Topics: Akathisia, Drug-Induced; Baclofen; Cyproheptadine; Dexmedetomidine; Diphenhydramine; GABA-A Receptor Antagonists; GABA-B Receptor Agonists; gamma-Aminobutyric Acid; Haloperidol; Humans; Lorazepam; Male; Melatonin; Neuroleptic Malignant Syndrome; Olanzapine; Receptors, GABA; Substance Withdrawal Syndrome; Substance-Related Disorders; Young Adult | 2019 |
4 other study(ies) available for dexmedetomidine and baclofen
Article | Year |
---|---|
Dexmedetomidine for acute baclofen withdrawal.
Topics: Adolescent; Adrenergic alpha-2 Receptor Agonists; Baclofen; Cerebral Palsy; Dexmedetomidine; GABA-B Receptor Agonists; Humans; Male; Quadriplegia; Substance Withdrawal Syndrome | 2015 |
Subcutaneous dexmedetomidine for baclofen withdrawal during palliative sedation.
Topics: Baclofen; Dexmedetomidine; Humans; Hypnotics and Sedatives; Infusions, Subcutaneous; Male; Middle Aged; Palliative Care; Substance Withdrawal Syndrome | 2020 |
Enteral baclofen withdrawal managed with intravenous dexmedetomidine: A case report.
Topics: Back Pain; Baclofen; Chronic Pain; Dexmedetomidine; Dose-Response Relationship, Drug; GABA-B Receptor Agonists; Humans; Hypnotics and Sedatives; Male; Middle Aged; Substance Withdrawal Syndrome | 2020 |
The indirect γ-aminobutyric acid (GABA) receptor agonist gabaculine-induced loss of the righting reflex may inhibit the descending analgesic pathway.
Topics: Adrenergic alpha-2 Receptor Agonists; Analgesics; Animals; Baclofen; Cyclohexanecarboxylic Acids; Dexmedetomidine; GABA Agonists; Ganglia, Spinal; Male; Mice; Morphine; Muscimol; Neural Pathways; Neurons; Pain Measurement; Rats; Reflex, Righting; Signal Transduction; Spinal Cord; Substance P | 2020 |